License: Creative Commons License Open Access by Alzheimers & Parkinsons Disease: Open Access is licensed under a Creative Commons Attribution 4.0 International License. Based on a work at SciRes Literature..

Manuscript should be submitted in Word Document (.doc or .docx) through online form or can be mailed to the particular journal's E-mail ID or to submit@scireslit.com, scireslit@gmail.com

Review Articles

Articles

We publish a wide range of article types in the Medical and Clinical Groups.

Our Vision

SciRes Literature main aim is to enhance the importance of science and technology to the scientific community and also to provide an equal opportunity to seek and share ideas to all our researchers and scientists without any barriers to develop their career and helping in their development of discovering the world.

Author Feedback

Joel Buxbaum

Joel Buxbaum

TSRI, USA

We have been investigating transthyretin (TTR) as a systemic amyloid precursor since the late 1980’s when it was noted that there were both autosomal dominant and sporadic forms of human TTR amyloidosis and that molecular genetics could be used to attack the problem.  We cloned the intact mutant and wild type TTR genes from the same patient, each on a 20kb single fragment of genomic DNA containing all the known sequences required for tissue specific expression and made transgenic lines expressing either the mutant or wild type gene in a tissue specific manner. 

  Authors submit all Proposals and manuscripts via Electronic Form! Submit a Manuscript!